Press "Enter" to skip to content

New patent expiration for Teva Womens drug ADDERALL 10

0
Copyright © DrugPatentWatch. Originally published at New patent expiration for Teva Womens drug ADDERALL 10

Annual Drug Patent Expirations for ADDERALL+10
Annual Drug Patent Expirations for ADDERALL+10

Adderall 10 is a drug marketed by Teva Womens and is included in one NDA. There is one patent protecting this drug.

The generic ingredient in ADDERALL 10 is amphetamine aspartate; amphetamine sulfate; dextroamphetamine saccharate; dextroamphetamine sulfate. Additional details are available on the amphetamine aspartate; amphetamine sulfate; dextroamphetamine saccharate; dextroamphetamine sulfate profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

Get the Daily Briefing or Try a trial

Copyright © DrugPatentWatch. Originally published at New patent expiration for Teva Womens drug ADDERALL 10
Get the DrugPatentWatch Daily Briefing

✓ Patent Expirations and Generic Entry

✓ Insightful Articles & Case Studies

✓ Patent Litigation & Challenges

✓ 505(b)(2) & Biosimilars

✓ Industry Trends

DrugPatentWatch - Make Better Decisions